Analysis of peripheral amyloid precursor protein in Angelman Syndrome

The neurobehavioral and molecular phenotype of Angelman Syndrome

(2015) Logan K. Wink et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

From UBE3A to Angelman syndrome: a substrate perspective

(2015) Gabrielle L. Sell et al.   Frontiers in Neuroscience

Impact of acamprosate on plasma amyloid-β precursor protein in youth: A pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker

(2014) Craig A. Erickson et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Angelman syndrome in Denmark. Birth incidence, genetic findings, and age at diagnosis

(2013) Line Granild Bie Mertz et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Abnormal Intracellular Accumulation and Extracellular Aβ Deposition in Idiopathic and Dup15q11.2-q13 Autism Spectrum Disorders

(2012) Jerzy Wegiel et al.   PLoS One

Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links

(2011) D. K. Sokol et al.   NEUROLOGY

Increased Secreted Amyloid Precursor Protein-α (sAPPα) in Severe Autism: Proposal of a Specific, Anabolic Pathway and Putative Biomarker

(2011) Balmiki Ray et al.   PLoS One

Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1KO Mice

(2011) Cara J. Westmark et al.   PLoS One

Fragile X Syndrome and Alzheimers Disease: Another Story About APP and β -Amyloid

(2010) J.S. Malter et al.   Current Alzheimer Research